Role of Renin-Angiotensin-Aldosterone System Inhibition in Autosomal Dominant Polycystic Kidney Disease
- 25 May 2018
- book chapter
- Published by Springer Nature
- p. 209-218
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Efficacy and Safety of Combined vs. Single Renin-Angiotensin-Aldosterone System Blockade in Chronic Kidney Disease: A Meta-AnalysisAmerican Journal of Hypertension, 2013
- Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney DiseaseNew England Journal of Medicine, 2012
- Sirolimus Produced S-Shaped Effect on Adult Polycystic Kidneys After 2-Year TreatmentTransplantation Proceedings, 2012
- Analysis of baseline parameters in the HALT polycystic kidney disease trialsKidney International, 2012
- Chronic treatment with lisinopril decreases proliferative and apoptotic pathways in autosomal recessive polycystic kidney diseasePediatric Nephrology, 2010
- Hypertension Awareness, Treatment, and Control in Adults With CKD: Results From the Chronic Renal Insufficiency Cohort (CRIC) StudyAmerican Journal of Kidney Diseases, 2010
- Prospective Change in Renal Volume and Function in Children with ADPKDClinical Journal of the American Society of Nephrology, 2009
- Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta‐analysisDiabetic Medicine, 2007
- Systematic Review of Combined Angiotensin-Converting Enzyme Inhibition and Angiotensin Receptor Blockade in HypertensionHypertension, 2005
- Effects of angiotensin converting enzyme inhibition in adult polycystic kidney diseaseKidney International, 1992